ELIZABETH CABRERA: Open Payments
NPI 1578960100 · WAIANAE, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,686 in 65 payments from 17 companies in 2025. Trend: 2023 $2,538 · 2024 $1,812 · 2025 $1,686
Food & beverage: $1,686
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 7 | $290 |
| Arcutis Biotherapeutics, Inc. | 3 | $259 |
| Amgen Inc. | 10 | $182 |
| Novartis Pharmaceuticals Corporation | 8 | $150 |
| ABBVIE INC. | 6 | $117 |
| GENZYME CORPORATION | 4 | $115 |
| REVANCE THERAPEUTICS, INC. | 1 | $103 |
| LEO Pharma Inc. | 4 | $97 |
| PFIZER INC. | 5 | $77 |
| Incyte Corporation | 4 | $69 |
Products named: DUPIXENT, Zoryve, OTEZLA, COSENTYX, DAXXIFY, RINVOQ, CIBINQO, ADBRY.
Industry payments across HI — which companies pay providers there.
